Novavax (NVAX) Goodwill (2010 - 2026)

Novavax's Goodwill history runs 17 years deep, the most recent figure standing at $112.9 million for Q1 2026.

• In Q1 2026, Goodwill rose 0.77% year-over-year to $112.9 million; the TTM figure through Mar 2026 stood at $112.9 million (up 0.77% YoY), while the FY2025 annual figure was $113.5 million, up 5.57% from the prior year.
• Goodwill was $112.9 million for Q1 2026 at Novavax, down from $113.5 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $130.8 million in Q1 2022 to a low of $107.5 million in Q4 2024.
• Historically, Goodwill has averaged $120.7 million across 5 years, with a median of $123.4 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Goodwill fell 15.67% in 2024, then climbed 5.57% in 2025.
• A 5-year view of Goodwill shows it stood at $126.3 million in 2022, then grew by 0.89% to $127.5 million in 2023, then declined by 15.67% to $107.5 million in 2024, then grew by 5.57% to $113.5 million in 2025, then slipped by 0.51% to $112.9 million in 2026.
• The last three Goodwill figures came in at $112.9 million (Q1 2026), $113.5 million (Q4 2025), and $113.1 million (Q3 2025), per Business Quant data.